|
|||||
|
|
Targeting α‐Synuclein as a therapy for Parkinson's disease: The battle begins |
|
| Authors: | C. Warren Olanow MD Jeffrey H. Kordower PhD |
| Affiliation: | 1. Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York 10029, New York, USA;2. Clintrex LLC;3. Department of Neurological Sciencs, Rush University Schoolf of Medicine, Chicago, Illinois, USA;4. Van Andel Research Institute, Grands Rapids Michigan 60612, USA |
| Abstract: | |
| Keywords: | |